Akhter Molla

536 total citations
9 papers, 248 citations indexed

About

Akhter Molla is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Akhter Molla has authored 9 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Virology. Recurrent topics in Akhter Molla's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (4 papers) and Hepatitis C virus research (3 papers). Akhter Molla is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (4 papers) and Hepatitis C virus research (3 papers). Akhter Molla collaborates with scholars based in United States and United Kingdom. Akhter Molla's co-authors include Warren M. Kati, Yaya Liu, Chih‐Ming Chen, William E. Kohlbrenner, Rakesh Tripathi, Debra Montgomery, Dale J. Kempf, Tim Middleton, Xiaoling Xuei and Hock Ben Lim and has published in prestigious journals such as Analytical Biochemistry, Biochemical and Biophysical Research Communications and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Akhter Molla

9 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Akhter Molla United States	6	117	92	44	42	38	9	248
Jennifer Timm United States	13	183 1.6×	70 0.8×	18 0.4×	36 0.9×	16 0.4×	20	305
Joan Zugay-Murphy United States	8	202 1.7×	130 1.4×	55 1.3×	68 1.6×	103 2.7×	9	363
Andrew Napoli United States	11	295 2.5×	80 0.9×	14 0.3×	41 1.0×	36 0.9×	23	597
Christopher J. Yarnold United Kingdom	7	119 1.0×	61 0.7×	17 0.4×	98 2.3×	20 0.5×	9	270
Carlo Boutton Belgium	7	102 0.9×	57 0.6×	70 1.6×	69 1.6×	11 0.3×	9	232
David D. Deininger United States	9	216 1.8×	186 2.0×	44 1.0×	88 2.1×	18 0.5×	14	417
Steve S. Carroll United States	9	138 1.2×	131 1.4×	31 0.7×	68 1.6×	58 1.5×	12	288
Annette von Delft United Kingdom	9	74 0.6×	75 0.8×	84 1.9×	15 0.4×	33 0.9×	15	252
M. E. Marongiu Italy	13	156 1.3×	152 1.7×	47 1.1×	133 3.2×	95 2.5×	36	453
Christine Burlein United States	11	184 1.6×	182 2.0×	107 2.4×	144 3.4×	61 1.6×	18	449

Countries citing papers authored by Akhter Molla

Since Specialization

Citations

This map shows the geographic impact of Akhter Molla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akhter Molla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akhter Molla more than expected).

Fields of papers citing papers by Akhter Molla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akhter Molla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akhter Molla. The network helps show where Akhter Molla may publish in the future.

Co-authorship network of co-authors of Akhter Molla

This figure shows the co-authorship network connecting the top 25 collaborators of Akhter Molla. A scholar is included among the top collaborators of Akhter Molla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akhter Molla. Akhter Molla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Randolph, John T., Peggy Huang, Rolf Wagner, et al.. (2013). High potency improvements to weak aryl uracil HCV polymerase inhibitor leads. Bioorganic & Medicinal Chemistry Letters. 23(15). 4367–4369. 5 indexed citations

Pratt, John K., Clarence J. Maring, Warren M. Kati, et al.. (2008). Des-A-ring benzothiadiazines: Inhibitors of HCV genotype 1 NS5B RNA-dependent RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 18(8). 2735–2738. 16 indexed citations

Larson, Daniel P., Rolf Wagner, Todd W. Rockway, et al.. (2007). Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(2). 568–570. 16 indexed citations

Stewart, Kent D., Kevin Steffy, John E. Harlan, et al.. (2007). Design and characterization of an engineered gp41 protein from human immunodeficiency virus-1 as a tool for drug discovery. Journal of Computer-Aided Molecular Design. 21(1-3). 121–130. 4 indexed citations

Middleton, Tim, Debra Montgomery, Hock Ben Lim, et al.. (2002). Microarray Compound Screening (<I>μ</I>ARCS) to Identify Inhibitors of HIV Integrase. 7(3). 259–266. 1 indexed citations

Middleton, Tim, Debra Montgomery, Hock Ben Lim, et al.. (2002). Microarray Compound Screening (μARCS) to Identify Inhibitors of HIV Integrase. SLAS DISCOVERY. 7(3). 259–266. 24 indexed citations

Sham, Hing L., David A. Betebenner, Thomas Herrin, et al.. (2001). Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir). Bioorganic & Medicinal Chemistry Letters. 11(11). 1351–1353. 15 indexed citations

Liu, Yaya, Warren M. Kati, Chih‐Ming Chen, et al.. (1999). Use of a Fluorescence Plate Reader for Measuring Kinetic Parameters with Inner Filter Effect Correction. Analytical Biochemistry. 267(2). 331–335. 161 indexed citations

Sham, Hing L., Chen Zhao, Kennan C. Marsh, et al.. (1996). Novel Azacyclic Ureas That Are Potent Inhibitors of HIV-1 Protease. Biochemical and Biophysical Research Communications. 225(2). 436–440. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact